Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...

Kaken will take the drug through phase I trials, after which J&J takes over. Under the terms, Kaken banks an up-front payment of $30 million and could collect more than $1.2 billion if development and ...

Cell competition in epithelial tissue eliminates transformed cells expressing activated oncoproteins to maintain epithelial homeostasis. Although the process is now understood to be of mechanochemical ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

New Delhi: Zydus Lifsciences has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control Organisation (CDSCO) for a phase IV study to evaluate the safety ...

The supernatants were ultracentrifuged for one hour at 100 000 g (4°C). Supernatants containing ... such as integrin precursors and cytoskeleton proteins under basal and inflammatory (+IFN-γ) ...

Sales of these and other alt proteins, which tasted and had the texture of hamburgers but used plant-based ingredients, had risen 27% over the year, and Burger King and McDonald’s had added them ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

G protein-coupled receptors (GPCRs), crucial for diverse physiological responses, have traditionally been investigated in ...